Residency · Lexington, KY
Sponsored by University of Kentucky College of Medicine
Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment.
Microorganisms · 2023 · 592 citations · James Mohler
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
European urology · 2026 · 37 citations · Patrick Hensley
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
The Lancet. Oncology · 2021 · 402 citations · Leonard Gomella
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Nature genetics · 2021 · 403 citations · James Mohler
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet (London, England) · 2022 · 224 citations · Leonard Gomella
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 134 citations ·
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
The Journal of urology · 2024 · 81 citations · Leonard Gomella
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Nature genetics · 2023 · 132 citations · James Mohler